Patrik Zeyen
Halle, NI 06120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.
Journal: International journal of molecular sciences
Published: May 24, 2022
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.
Journal: European journal of medicinal chemistry
Published: January 21, 2022
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity.
Journal: International journal of molecular sciences
Published: December 11, 2021
Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.
Journal: European journal of medicinal chemistry
Published: June 17, 2021
Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: March 31, 2021
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.
Journal: PLoS neglected tropical diseases
Published: July 20, 2020
Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1.
Journal: European journal of medicinal chemistry
Published: February 17, 2020
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity.
Journal: Journal of medicinal chemistry
Published: December 01, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026